Camber launches generic ToradolKetorolac tromethamine injection is indicated for the short-term management of moderately severe acute pain that requires analgesia at the opioid level. Sandoz releases generic AbraxaneThe single-dose 100mg vial for intravenous use is FDA approved for metastatic breast cancer. FDA gives Alembic nod for generic Lastacaft Alcaftadine ophthalmic solution, 0.25% is used to temporarily relieve itchy eyes due to allergens. FDA approves Dong-A ST’s Stelara biosimilar Imuldosa is used for the treatment of patients with autoimmune diseases such as plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. Biden administration releases preliminary list of $2 generic drugs for Medicare recipients Participation in the model would be voluntary for Part D sponsors and, pending further development, could start as early as January 2027. Teva’s Prolia biosimilar candidate accepted for review by FDA, EU EMA Prolia is indicated to treat certain conditions that lead to high risk for fracture, including osteoporosis in postmenopausal women. Glenmark pays $25M to resolve alleged False Claims Act liability for drug price-fixing The government alleged that between 2013 and 2015, Glenmark paid and received compensation prohibited by the Anti-Kickback Statute. Camber touts 8 generic product launches in Q3-2024 The company launched several other generics during Q1 and Q2. Elite rolls out generic Tylenol with Codeine Acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain. Camber releases generic Lunesta Eszopiclone tablets are indicated for the treatment of insomnia. 1 2 3 4 5 Next Last